|
|
 |
|
Viewing report
|
|
|
|
Antibacterial Drugs - Global Strategic Business Report
Global Industry Analysts, Inc., April 2010, Pages: 719
This report analyzes the worldwide markets for Antibacterial Drugs in US$ Million by the following drug classes: Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, and Other Antibacterial Drugs. The report provides separate comprehensive analytics for the US, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for each region for the period 2006 through 2015. The report profiles 124 companies including many key and niche players such as Abbott Laboratories, AstraZeneca PLC, Bayer HealthCare AG, Bristol-Myers Squibb Co., Cubist Pharmaceuticals, Inc., Daiichi Sankyo Company, Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Pfizer, Inc., and Wyeth Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Anti-Infectives - Global Strategic Business Report
Antibiotics - Global Strategic Business Report
Antibiotic Resistance 2012: The Antibiotic Development Pipeline and Strategies to Combat Antibiotic Resistance
The Global Antibacterials Market: R&D Pipelines, Market Analysis and Competitive Landscape
Opthalmic Pharmaceutical Drugs - Global Strategic Business Report
The Global Market for AntiMicrobials and Antifungals; Challenging Resistance to 2015
Antibiotics and Drug Resistance 2008
Anti-Bacterials Market to 2016 - Cephalosporins, Penicillins, Macrolides and Fluoroquinolones to Drive the Anti-Bacterials Market
Antivirals - Global Strategic Business Report
Pipeline Insight: Antibacterials
|
|
|
|
